2010
DOI: 10.2217/rme.09.78
|View full text |Cite
|
Sign up to set email alerts
|

Cultivating Regenerative Medicine Innovation in China

Abstract: China has been able to catapult itself into the forefront of regenerative medicine but needs to address current regulatory challenges in order to secure its position in this emerging field.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(20 citation statements)
references
References 21 publications
1
18
0
1
Order By: Relevance
“…In fact, it was estimated that at least 200 hospitals in China continued to offer unproven therapies [18]. Chinese authorities had little influence over companies such as Belike Biotechnology, which claimed to supply stem cells to hospitals for treatment of a wide range of conditions [18,19].…”
Section: Post Hoc Pragmatism and Its Effects On Accountable Researchmentioning
confidence: 99%
“…In fact, it was estimated that at least 200 hospitals in China continued to offer unproven therapies [18]. Chinese authorities had little influence over companies such as Belike Biotechnology, which claimed to supply stem cells to hospitals for treatment of a wide range of conditions [18,19].…”
Section: Post Hoc Pragmatism and Its Effects On Accountable Researchmentioning
confidence: 99%
“…It operates a State Key Laboratory on stem cell engineering and reprogramming, for which it has received over US$ 4 million in support from the local government. 84 Although the Web sites of some stem cell companies contain a brief warning that the treatments are not FDAapproved, most offer oversimplified descriptions of the process, misleading statements regarding the known risks, and moving testimonials from satisfied patients. Among the most troublesome statements were: "It is important for any potential patient to receive the treatment as soon as possible after .…”
Section: Commercial Availability Of Stem Cell Treatmentsmentioning
confidence: 99%
“…En el tratamiento innovador el enfermo debe saber claramente los riesgos que conlleva un tratamiento no comprobado 27 . El tema de tratamientos innovadores con CM, es objeto de especial interés y controversia 25,28 .…”
Section: Ensayos Clínicos Innovación Médica éTica De La Investigaciunclassified